Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
10/2006
10/12/2006US20060229313 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
10/12/2006US20060229298 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/12/2006US20060229297 (THIO) Carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists
10/12/2006US20060229254 Compounds having prolyl oligopeptidase inhibitory activity
10/12/2006CA2603030A1 Benzyloxypropylamine derivative
10/11/2006EP1710240A1 Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists
10/11/2006EP1710238A1 Benzophenones as inhibitors of reverse transcriptase
10/11/2006EP1709024A1 Piperazino sensitisers
10/11/2006EP1709023A1 Selective estrogen receptor modulators
10/11/2006EP1709022A1 Selective estrogen receptor modulators
10/11/2006EP1709021A1 Selective estrogen receptor modulators for the treatment of vasomotor symptoms
10/11/2006EP1709020A2 Processes for preparing novel methylene blue derivative
10/11/2006EP1708992A1 Sulfonamide derivatives for the treatment of diseases
10/11/2006EP1708986A1 Method for the catalytic reduction of amides
10/11/2006EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
10/11/2006EP1469851B1 Melanocortin receptor agonists
10/11/2006EP1385625B1 A nickel-rhenium catalyst for use in reductive amination processes
10/11/2006CN1845913A High-purity piperazine pyrophosphate and method for producing same
10/11/2006CN1845912A Piperazine-based sensitisers
10/11/2006CN1845758A Aminoalkyl substituted esters and amides of fumaric acid for neutralising malodor
10/11/2006CN1845740A Piperazine derivatives for the treatment of HIV infections
10/10/2006US7119223 Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators
10/10/2006US7119214 dibenzofuranyl, dibenzothiophenyl or fluorenyl thioacetamides used for prophylaxis of sleep disorders
10/10/2006US7119206 drugs such as 12-[4-(2-Piperidin-1-yl-ethoxy)-phenyl]-7,12-dihydro-benzo[a]anthracene-3,9-diol, used for prevention of bone and cardiovascular disorders, as hypotensive, thrombolytic and anticholesterol agents
10/10/2006US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
10/10/2006US7119085 Inhibit amyloid protein deposits
10/10/2006US7119080 Boronic ester and acid compounds, synthesis and uses
10/10/2006CA2152191C Therapeutic agent for glaucoma and ocular hypotensive agent
10/05/2006WO2006105127A2 Hydroxysteroid dehydrogenase inhibitors
10/05/2006WO2006103527A1 Aromatic substituted pentadienoic acid amide for combination with anti-infective drugs
10/05/2006WO2006103342A2 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
10/05/2006WO2006086374A3 3-amino-2-aminomethylphenol derivatives and colorants comprising these compounds
10/05/2006WO2006059245A3 Compounds for the treatment of cns and amyloid associated diseases
10/05/2006WO2006007496A3 Mitotic kinesin inhibitors
10/05/2006WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators
10/05/2006US20060223995 Superhigh purity ionic liquid
10/05/2006US20060223853 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents
10/05/2006US20060223842 such as (5-acetyl-1-methyl-1H-pyrrol-2-yl)acetyl methanesulphonamide, used for the of treatment of psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), skin disorders, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and reperfusion injuries after ischemia
10/05/2006US20060223789 Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates
10/05/2006US20060223784 Method and compositions for temporarily incapacitating subjects
10/04/2006EP1707564A2 Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them
10/04/2006EP1707560A1 Hydroxamic acid derivative and age generation inhibitor containing the derivative
10/04/2006EP1707265A1 Superhigh purity ionic liquid
10/04/2006EP1706399A1 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
10/04/2006EP1706393A1 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
10/04/2006EP1706375A2 Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders
10/04/2006EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/04/2006CN1842515A Cathepsin inhibitors
10/04/2006CN1840528A Process for preparing N-formyl morpholine
10/04/2006CN1840527A Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them
10/04/2006CN1277824C Piperazine derivatives
10/04/2006CN1277809C Benzal indone and benzyl indone derivative(s), and its preparing method and use
10/03/2006US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/03/2006US7115768 Particularly (adamantylcarbonylamino)acetic acid derivatives
10/03/2006US7115752 Substituted cyclic compounds
10/03/2006US7115750 Melanin concentrating hormone antagonist
10/03/2006US7115664 Peptidomimetic ligands for cellular receptors and ion channels
10/03/2006US7115661 Methods and compositions for mitigating pain
10/03/2006US7115652 Aspartyl protease inhibitors
10/03/2006US7115632 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
10/03/2006US7115627 Trypsin-like serine protease enzyme inhibitors; anticoagulants
10/03/2006US7115618 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
10/03/2006US7115607 Substituted piperazinyl amides and methods of use
10/03/2006US7115600 Histamine-3 receptor modulators
10/03/2006CA2352405C New diphenylurea derivatives, their preparation process and the pharmaceutical compounds that contain them
10/03/2006CA2265544C Novel cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing methods
10/03/2006CA2189221C Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
09/2006
09/28/2006WO2006100568A1 Preparation of optically pure beta-amino acids having affinity for the alpha-2-delta protein
09/28/2006WO2006100502A1 11-beta-hydroxysteroid dehydrogenase inhibitors
09/28/2006WO2006099862A1 Addition salts of tolperisone, processes for their preparation and use thereof
09/28/2006WO2006099684A1 Copper complexes
09/28/2006WO2006051314A8 Guanidine derivatives as inhibitors of ddah
09/28/2006WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
09/28/2006WO2004070352A3 Methods, mixtures, kits and compositions pertaining to analyte determination
09/28/2006US20060217568 Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups
09/28/2006US20060217560 D-t-3',4'-ethylenedioxy-p4 derivatives; glucosyl ceramide inhibitors lower glycosphingolipid levels; anticarcinogenic, antitumor agents; angiogenesis inhibitors; tumor antigens
09/28/2006US20060217379 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
09/28/2006DE102005014080A1 Additionssalze des Tolperison, Verfahren zu deren Herstellung und Verwendung derselben Addition salts of tolperisone, processes for their preparation and use thereof
09/28/2006CA2602418A1 Preparation of optically pure beta-amino acids having affinity for the alpha-2-delta protein
09/28/2006CA2602208A1 Addition salts of tolperisone, processes for their preparation and use thereof
09/28/2006CA2598589A1 11-beta-hydroxysteroid dehydrogenase inhibitors
09/27/2006EP1705169A2 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
09/27/2006EP1704856A1 Hsp90 family protein inhibitor
09/27/2006EP1703909A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
09/27/2006EP1703908A1 Aryl sulfonamide compounds and uses related thereto
09/27/2006EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents
09/27/2006CN1839124A Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament
09/27/2006CN1276914C Novel cyclohexyl sulphones
09/26/2006US7112674 cyclized; organic light-emitting diodes (OLED); eliminate drawbacks of Alq3 as emitter and a host material for dopants; narrower emission bands; broad spectral range; low driver voltages; high photometric efficiency (low power consumption); high luminance (emission intensity); high thermal stability
09/26/2006US7112586 Substituted diamine derivatives useful as motilin antagonists
09/26/2006US7112554 Herbicides; broad active spectrum; on soil and above ground plant parts use
09/26/2006CA2424965C Novel coupler for use in oxidative hair dyeing
09/26/2006CA2278694C Sulfamide-metalloprotease inhibitors
09/26/2006CA2243316C Metal complexes that contain perfluoroalkyl, process for their production and their use in nmr diagnosis
09/21/2006WO2006098342A1 Piperazinyl compounds
09/21/2006WO2006098308A1 Novel anthranilic acid derivative or salt thereof
09/21/2006WO2006097169A1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof
09/21/2006WO2006048152A3 Dicarboxamide derivatives and their use as factor xa inhibitors
09/21/2006WO2005037207A3 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms)
09/21/2006US20060211860 Compounds for the treatment of Alzheimer's disease